Life Sciences: Industry trends & investment considerations with Nick Galakatos, Blackstone
UBS On-Air: Market Moves
00:00
Navigating FDA Oversight and Regulatory Stability
Nick emphasizes the FDA's science‑based review process and notes no material changes in review timelines despite policy discussions.
Play episode from 08:01
Transcript
